We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$255M
AUM Growth
-$53M
Cap. Flow
-$59.9M
Cap. Flow %
-23.49%
Top 10 Hldgs %
4.95%
Holding
921
New
282
Increased
115
Reduced
203
Closed
319

Sector Composition

Rank Sector Weight
1 Healthcare 18.37%
2 Industrials 15.52%
3 Consumer Discretionary 13.06%
4 Technology 12.07%
5 Financials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RST
126
DELISTED
ROSETTA STONE INC
RST
$690K 0.27%
64,052
-25,428
-28% -$285K
BBOX
127
DELISTED
Black Box Corp
BBOX
$684K 0.27%
79,942
+19,752
+33% +$174K
VATE icon
128
INNOVATE Corp
VATE
$113M
$667K 0.26%
11,350
-5,575
-33% -$320K
GEO icon
129
The GEO Group
GEO
$4.1B
$659K 0.26%
+22,283
New +$700K
TBI
130
Trueblue
TBI
$237M
$659K 0.26%
24,859
-31,520
-56% -$841K
CRS icon
131
Carpenter Technology
CRS
$29.9B
$656K 0.26%
+17,514
New +$649K
SAH icon
132
Sonic Automotive
SAH
$3.13B
$640K 0.25%
+32,918
New +$627K
QDEL icon
133
QuidelOrtho
QDEL
$1.11B
$639K 0.25%
+23,532
New +$583K
NVRI icon
134
Enviri
NVRI
$635M
$629K 0.25%
39,070
+4,429
+13% +$63.9K
DCO icon
135
Ducommun
DCO
$2.69B
$624K 0.24%
+19,773
New +$614K
HVT icon
136
Haverty Furniture Companies
HVT
$392M
$621K 0.24%
24,758
-21,873
-47% -$533K
CCXI
137
DELISTED
ChemoCentryx, Inc.
CCXI
$614K 0.24%
+65,553
New +$481K
SCLN
138
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$606K 0.24%
55,104
-40,328
-42% -$403K
LMAT icon
139
LeMaitre Vascular
LMAT
$2.23B
$603K 0.24%
19,317
-4,970
-20% -$144K
CCMP
140
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$602K 0.24%
8,157
+2,103
+35% +$159K
NOMD icon
141
Nomad Foods
NOMD
$1.62B
$596K 0.23%
+42,245
New +$540K
VC icon
142
Visteon
VC
$2.67B
$596K 0.23%
+5,835
New +$577K
AORT icon
143
Artivion
AORT
$1.2B
$592K 0.23%
29,676
+3,932
+15% +$70.4K
OFS icon
144
OFS Capital
OFS
$45.8M
$592K 0.23%
+41,385
New +$589K
CLS icon
145
Celestica
CLS
$39.2B
$588K 0.23%
43,329
-9,232
-18% -$129K
CMRX
146
DELISTED
Chimerix, Inc.
CMRX
$587K 0.23%
107,764
+494
+0.5% +$2.6K
CZZ
147
DELISTED
Cosan Limited
CZZ
$587K 0.23%
+91,603
New +$674K
CCS icon
148
Century Communities
CCS
$1.96B
$586K 0.23%
23,622
-12,327
-34% -$318K
GSM icon
149
FerroAtlántica
GSM
$626M
$586K 0.23%
49,059
-26,354
-35% -$267K
RGEN icon
150
Repligen
RGEN
$7.52B
$581K 0.23%
+14,012
New +$532K

Similar funds

TFS Capital's Q2 2017 Portfolio in Review

As of Q2 2017, TFS Capital held 921 positions worth $255M, down 17% from $308M the previous quarter. Its ten largest holdings account for 4.9% of the portfolio.

TFS Capital withdrew a net $59.9M in Q2 2017, closing 319 positions and reducing 203 holdings. Its most notable exit was ePlus, an estimated $1.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, TFS Capital opened a new position in MYR Group worth $1.06M.

  • TFS Capital's largest Q2 2017 buy was MYR Group: 34,070 shares worth $1.06M.
  • TFS Capital added most to ModivCare in Q2 2017, an estimated $871K increase.
  • TFS Capital's biggest Q2 2017 reduction was Insight Enterprises, cutting an estimated $1.31M.
  • TFS Capital fully exited ePlus in Q2 2017, selling an estimated $1.71M.
  • TFS Capital's ten largest holdings make up 4.9% of its $255M portfolio in Q2 2017.
  • TFS Capital opened 282 new positions and closed 319 in Q2 2017.
  • TFS Capital's portfolio value fell 17% quarter-over-quarter to $255M.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.